Prange Karen — SEC Form 4 filings
SEC reporting owner CIK 1566083. 13 Form 4 filings on record with FilingPulse; latest filed 2026-08-07.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-02-09 to 2026-08-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 12,664 shares, $456,765 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 6,100 shares @ $38.12 ($232,532) in AtriCure, Inc., filed 2025-03-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AtriCure, Inc. (ATRC) | Director | 6 | — | 3 legs · 12,664 sh · $456,765 | 3 |
| Embecta Corp. (EMBC) | Director | 3 | — | — | 3 |
| NEVRO CORP (NVRO) | Director | 2 | — | — | 2 |
| Outset Medical, Inc. (OM) | Director | 2 | — | — | 2 |
Form 4 filings — Prange Karen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-07 | 4 | AtriCure, Inc. (ATRC) | Sale (S): 3,564 @ $38.80 | EDGAR |
| 2026-06-05 | 4 | Outset Medical, Inc. (OM) | Grant/award (A): 10,667 @ $0 | EDGAR |
| 2026-05-22 | 4 | AtriCure, Inc. (ATRC) | Sale (S): 3,000 @ $28.65 | EDGAR |
| 2026-05-20 | 4 | AtriCure, Inc. (ATRC) | Grant/award (A): 6,144 @ $0 | EDGAR |
| 2026-02-13 | 4 | Embecta Corp. (EMBC) | Grant/award (A): 22,841 @ $0 | EDGAR |
| 2026-01-12 | 4 | Outset Medical, Inc. (OM) | Grant/award (A): 18,667 @ $0 | EDGAR |
| 2025-05-21 | 4 | AtriCure, Inc. (ATRC) | Grant/award (A): 5,401 @ $0 | EDGAR |
| 2025-04-03 | 4 | NEVRO CORP (NVRO) | Disposition to issuer (D): 33,948 | EDGAR |
| 2025-03-07 | 4 | AtriCure, Inc. (ATRC) | Sale (S): 6,100 @ $38.12 | EDGAR |
| 2025-02-14 | 4 | Embecta Corp. (EMBC) | Grant/award (A): 13,839 @ $0 | EDGAR |
| 2024-05-28 | 4 | NEVRO CORP (NVRO) | Grant/award (A): 19,169 @ $0 | EDGAR |
| 2024-05-14 | 4 | AtriCure, Inc. (ATRC) | Grant/award (A): 7,788 @ $0 | EDGAR |
| 2024-02-09 | 4 | Embecta Corp. (EMBC) | Grant/award (A): 11,455 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1566083 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →